title: Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification.
abstract: The incidence of adenocarcinoma of the esophagogastric junction (AEG) has been increasing in Western countries. It is unclear, however, whether similar changes are occurring in Asia. We therefore investigated the incidence of AEG in Korea, and assessed the clinical characteristics of three types of AEG based on Siewert's classification. We retrospectively reviewed the medical records of 16 811 patients diagnosed with esophageal squamous cell carcinoma (ESC, n= 1450) or gastric noncardiac adenocarcinoma (GNCA, n= 14 751) between 1992 and 2006. The patients were divided into three 5-year cohorts (cohort A [1992-1996], n= 2734, cohort B [1997-2001], n= 5727, and cohort C [2002-2006], n= 8350), and the ratios of AEG (n= 610) to non-AEG (ESC and GNCA) in each cohort were compared. Using Siewert's classification, the tumors were categorized into one of three types, and patient demographic features and 5-year survival rates were compared. The ratio of AEG to non-AEG cases did not change over time (0.037, 0.034, and 0.039 for cohorts A, B, and C, respectively; P= 0.40). Of the 610 patients with AEG, 23 (3.7%) had type 1 tumors, 47 (7.7%) had type 2, and 540 (88.5%) had type 3. The 5-year survival rate of patients with type 1 AEG was much lower (4.8 +/- 4.7%) than that of those with type 2 (47.9 +/- 7.8%) and type 3 (47.4 +/- 2.5%) tumors. Unlike in Western countries, the ratio of AEG to non-AEG cases has not increased over time in Korea. Type 1 AEG was rarer and associated with a more unfavorable prognosis in Korea than in Western countries.
authors.affiliation: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
authors.forename: J-W
authors.initials: JW
authors.lastname: Chung
authors.forename: G H
authors.initials: GH
authors.lastname: Lee
authors.forename: K-S
authors.initials: KS
authors.lastname: Choi
authors.forename: D-H
authors.initials: DH
authors.lastname: Kim
authors.forename: K W
authors.initials: KW
authors.lastname: Jung
authors.forename: H J
authors.initials: HJ
authors.lastname: Song
authors.forename: K D
authors.initials: KD
authors.lastname: Choi
authors.forename: H-Y
authors.initials: HY
authors.lastname: Jung
authors.forename: J-H
authors.initials: JH
authors.lastname: Kim
authors.forename: J H
authors.initials: JH
authors.lastname: Yook
authors.forename: B S
authors.initials: BS
authors.lastname: Kim
authors.forename: S-J
authors.initials: SJ
authors.lastname: Jang
mesh_terms: D000230:Adenocarcinoma / Q000145:classification / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000145:classification / Q000453:epidemiology / Q000401:mortality / Q000473:pathology / Q000601:surgery; D002299:Cardia / Q000473:pathology; D004938:Esophageal Neoplasms / Q000145:classification / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D004943:Esophagogastric Junction; D005260:Female; D005743:Gastrectomy; D006801:Humans; D053208:Kaplan-Meier Estimate; D007723:Korea / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D015995:Prevalence; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000145:classification / Q000453:epidemiology* / Q000401:mortality / Q000601:surgery